ARTICLE | Clinical News
Tuberculosis vaccine: Phase II started
January 16, 2012 8:00 AM UTC
Intercell said Statens Serum Institut (Copenhagen, Denmark) began a double-blind, South African and Tanzanian Phase II trial to evaluate 2 doses of H1IC in HIV-infected patients. The European and Dev...